Why the APOE4 protein raises Alzheimer’s risk
Structural basis for ApoE4-induced Alzheimer's disease
Researchers are using advanced computer simulations to understand how the APOE4 form of a common protein can lead to Alzheimer's in people who carry that gene.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11304506 on NIH RePORTER |
What this research studies
This project uses high-resolution computer simulations to map how different APOE protein versions fold and move. Scientists will build atom-level models that capture how APOE4 behaves compared with the neutral APOE3 and protective APOE2 forms. By tracking the protein’s shapes and how it tends to clump or interact with other molecules, they aim to find structural changes that may make brain cells vulnerable. Those findings could point to precise spots for new drugs or treatments to block APOE4’s harmful effects.
Who could benefit from this research
Good fit: People who carry one or two copies of the APOE-e4 gene variant or those with a family history of early Alzheimer’s are the most directly relevant group.
Not a fit: People without the APOE-e4 variant or whose memory problems are caused by non-Alzheimer's conditions are less likely to receive direct benefits from this specific research.
Why it matters
Potential benefit: If successful, the work could reveal exact molecular targets for therapies that prevent APOE4-driven brain damage and reduce Alzheimer's risk in APOE4 carriers.
How similar studies have performed: Structural and computational approaches have yielded useful insights in other protein-linked diseases, but applying atomistic Markov state models specifically to APOE4 is relatively new and exploratory.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Bowman, Gregory — University of Pennsylvania
- Study coordinator: Bowman, Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.